Cargando…
Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study
OBJECTIVES: Preclinical data showed poly(methyl methacrylate) (PMMA) loaded with microsilver to be effective against a variety of bacteria. The purpose of this study was to assess patient safety of PMMA spacers with microsilver in prosthetic hip infections in a prospective cohort study. METHODS: A t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719530/ https://www.ncbi.nlm.nih.gov/pubmed/31537996 http://dx.doi.org/10.1302/2046-3758.88.BJR-2018-0270.R1 |
_version_ | 1783447955704905728 |
---|---|
author | Alt, Volker Rupp, Markus Lemberger, Karsten Bechert, Thorsten Konradt, Thomas Steinrücke, Peter Schnettler, Reinhard Söder, Stephan Ascherl, Rudolf |
author_facet | Alt, Volker Rupp, Markus Lemberger, Karsten Bechert, Thorsten Konradt, Thomas Steinrücke, Peter Schnettler, Reinhard Söder, Stephan Ascherl, Rudolf |
author_sort | Alt, Volker |
collection | PubMed |
description | OBJECTIVES: Preclinical data showed poly(methyl methacrylate) (PMMA) loaded with microsilver to be effective against a variety of bacteria. The purpose of this study was to assess patient safety of PMMA spacers with microsilver in prosthetic hip infections in a prospective cohort study. METHODS: A total of 12 patients with prosthetic hip infections were included for a three-stage revision procedure. All patients received either a gentamicin-PMMA spacer (80 g to 160 g PMMA depending on hip joint dimension) with additional loading of 1% (w/w) of microsilver (0.8 g to 1.6 g per spacer) at surgery 1 followed by a gentamicin-PMMA spacer without microsilver at surgery 2 or vice versa. Implantation of the revision prosthesis was carried out at surgery 3. RESULTS: In total, 11 of the 12 patients completed the study. No argyria or considerable differences in laboratory parameters were detected. Silver blood concentrations were below or around the detection limit of 1 ppb in ten of the 11 patients. A maximum of 5.6 ppb at 48 hours after implantation of the silver spacer, which is below the recommended maximum level of 10 ppb, was found in one patient. No silver was detected in the urine. Drainage fluids showed concentrations between 16.1 ppb and 23.3 ppb at 12 hours after implantation of the silver spacers, and between 16.8 ppb to 25.1 ppb at 48 hours after implantation. Pathohistological assessment of the periprosthetic membrane did not reveal any differences between the two groups. CONCLUSION: Microsilver-loaded gentamicin-PMMA spacers showed good biocompatibility and the broad antimicrobial activity warrants further clinical research to assess its effectivity in reducing infection rates in prosthetic joint infection. Cite this article: V. Alt, M. Rupp, K. Lemberger, T. Bechert, T. Konradt, P. Steinrücke, R. Schnettler, S. Söder, R. Ascherl. Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study. Bone Joint Res 2019;8:387–396. DOI: 10.1302/2046-3758.88.BJR-2018-0270.R1. |
format | Online Article Text |
id | pubmed-6719530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
record_format | MEDLINE/PubMed |
spelling | pubmed-67195302019-09-19 Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study Alt, Volker Rupp, Markus Lemberger, Karsten Bechert, Thorsten Konradt, Thomas Steinrücke, Peter Schnettler, Reinhard Söder, Stephan Ascherl, Rudolf Bone Joint Res Infection OBJECTIVES: Preclinical data showed poly(methyl methacrylate) (PMMA) loaded with microsilver to be effective against a variety of bacteria. The purpose of this study was to assess patient safety of PMMA spacers with microsilver in prosthetic hip infections in a prospective cohort study. METHODS: A total of 12 patients with prosthetic hip infections were included for a three-stage revision procedure. All patients received either a gentamicin-PMMA spacer (80 g to 160 g PMMA depending on hip joint dimension) with additional loading of 1% (w/w) of microsilver (0.8 g to 1.6 g per spacer) at surgery 1 followed by a gentamicin-PMMA spacer without microsilver at surgery 2 or vice versa. Implantation of the revision prosthesis was carried out at surgery 3. RESULTS: In total, 11 of the 12 patients completed the study. No argyria or considerable differences in laboratory parameters were detected. Silver blood concentrations were below or around the detection limit of 1 ppb in ten of the 11 patients. A maximum of 5.6 ppb at 48 hours after implantation of the silver spacer, which is below the recommended maximum level of 10 ppb, was found in one patient. No silver was detected in the urine. Drainage fluids showed concentrations between 16.1 ppb and 23.3 ppb at 12 hours after implantation of the silver spacers, and between 16.8 ppb to 25.1 ppb at 48 hours after implantation. Pathohistological assessment of the periprosthetic membrane did not reveal any differences between the two groups. CONCLUSION: Microsilver-loaded gentamicin-PMMA spacers showed good biocompatibility and the broad antimicrobial activity warrants further clinical research to assess its effectivity in reducing infection rates in prosthetic joint infection. Cite this article: V. Alt, M. Rupp, K. Lemberger, T. Bechert, T. Konradt, P. Steinrücke, R. Schnettler, S. Söder, R. Ascherl. Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study. Bone Joint Res 2019;8:387–396. DOI: 10.1302/2046-3758.88.BJR-2018-0270.R1. 2019-09-03 /pmc/articles/PMC6719530/ /pubmed/31537996 http://dx.doi.org/10.1302/2046-3758.88.BJR-2018-0270.R1 Text en © 2019 Author(s) et al. https://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed. |
spellingShingle | Infection Alt, Volker Rupp, Markus Lemberger, Karsten Bechert, Thorsten Konradt, Thomas Steinrücke, Peter Schnettler, Reinhard Söder, Stephan Ascherl, Rudolf Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study |
title | Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study |
title_full | Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study |
title_fullStr | Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study |
title_full_unstemmed | Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study |
title_short | Safety assessment of microsilver-loaded poly(methyl methacrylate) (PMMA) cement spacers in patients with prosthetic hip infections: Results of a prospective cohort study |
title_sort | safety assessment of microsilver-loaded poly(methyl methacrylate) (pmma) cement spacers in patients with prosthetic hip infections: results of a prospective cohort study |
topic | Infection |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719530/ https://www.ncbi.nlm.nih.gov/pubmed/31537996 http://dx.doi.org/10.1302/2046-3758.88.BJR-2018-0270.R1 |
work_keys_str_mv | AT altvolker safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT ruppmarkus safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT lembergerkarsten safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT bechertthorsten safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT konradtthomas safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT steinruckepeter safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT schnettlerreinhard safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT soderstephan safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy AT ascherlrudolf safetyassessmentofmicrosilverloadedpolymethylmethacrylatepmmacementspacersinpatientswithprosthetichipinfectionsresultsofaprospectivecohortstudy |